Systemic reaction to omalizumab

Ann Allergy Asthma Immunol. 2006 Aug;97(2):267. doi: 10.1016/S1081-1206(10)60027-0.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetates / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Albuterol / analogs & derivatives
  • Albuterol / therapeutic use
  • Anti-Asthmatic Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Arthritis / complications
  • Asthma / complications
  • Asthma / drug therapy
  • Cyclopropanes
  • Depression / complications
  • Drug Hypersensitivity / drug therapy
  • Drug Hypersensitivity / immunology*
  • Drug Hypersensitivity / physiopathology*
  • Drug Therapy, Combination
  • Epinephrine / therapeutic use
  • Female
  • Humans
  • Hypersensitivity / complications
  • Hypersensitivity / drug therapy
  • Hypertension / complications
  • Methylprednisolone / therapeutic use
  • Omalizumab
  • Quinolines / therapeutic use
  • Rhinitis / complications
  • Rhinitis / drug therapy
  • Salmeterol Xinafoate
  • Seizures / chemically induced
  • Sulfides
  • Syncope / chemically induced

Substances

  • Acetates
  • Adrenal Cortex Hormones
  • Anti-Asthmatic Agents
  • Anti-Inflammatory Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cyclopropanes
  • Quinolines
  • Sulfides
  • Omalizumab
  • Salmeterol Xinafoate
  • montelukast
  • Albuterol
  • Methylprednisolone
  • Epinephrine